A recent trio of hotly contested proxy fights involving Norton Rose Fulbright’s Special Situations Team helped further clarify and define the rights of a board of directors to determine the timing of a shareholders’ meeting. Bioniche Life Sciences Inc. With the July 18, 2013, decision of Justice Brown of the Ontario Superior Court in Wells v … Continue reading
